Patent · US Active

Stabilizing camptothecin pharmaceutical compositions

US10993914B2 · kind B2 · utility

7Cited by

101References

36Claims

0Family size

Assignee

IPSEN BIOPHARM LIMITED · GB

Inventors

Daryl C. Drummond · Lincoln, US
Dmitri B. Kirpotin · San Francisco, US
Mark E. Hayes · Mill Valley, US
Charles O. Noble · San Francisco, US
Kevin Kesper · Watertown, US
Antoine M. Awad · Dedham, US
Douglas J. Moore · Newton, US
Andrew J. O'Brien · Franklin, US

Key dates

Filing date	Sep 11, 2019
Grant date	May 4, 2021
Priority date	—
Expiry date	Sep 11, 2039

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY10S977/907
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Irinotecan phospholipid liposomes with improved storage stability are provided, with related methods of treatment and manufacture. The irinotecan liposomes can have reduced formation of lyso-phosphatidylcholine (lyso-PC) during storage, and prior to administration to a patient.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.